| Recruitment status | Recruiting |
| Unique ID issued by UMIN | UMIN000025542 |
| Receipt No. | R000029405 |
| Official scientific title of the study | Pathological biomarker search for the radiotherapy convalescence prediction factor of the esophageal cancer by the highly sensitive fluorescence immunostaining |
| Date of disclosure of the study information | 2017/01/05 |
| Last modified on | 2017/01/05 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Pathological biomarker search for the radiotherapy convalescence prediction factor of the esophageal cancer by the highly sensitive fluorescence immunostaining | |
| Title of the study (Brief title) | Pathological biomarker search for the radiotherapy convalescence prediction factor of the esophageal cancer by the highly sensitive fluorescence immunostaining | |
| Region |
|
|
| Condition | ||
| Condition | Esophageal cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Pathological biomarker search for the radiotherapy convalescence prediction factor of the esophageal cancer by the histopathological examination with the expression of various cancer-related factors using the high sensitive fluorescence immunostaining |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Relation between various cancer-related factors and progress-free survival period |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Squamous cell carcinoma, adenosquamous cell carcinoma or basaloid carcinoma
2) Resectable disease 3) Clinical stage I, II or III excluding T4b disease (UICC tumor, node, metastasis system TNM classification) 4) Age 20 to 85 years 5) Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 6) No previous surgery for esophageal cancers 7) No previous chemo- or radiotherapy for any malignancies 8) Sufficient organ function 9) Written informed consent |
|||
| Key exclusion criteria | 1) Other primary cancer
2) Psychiatric disease 3) Serious complications 4) Cardiovascular disease or heart failure occur within 3 months 5) Cerebrovascular disease occur within 3 months 6) Active infection 7) With cardiac pacemaker or defibrillator 8) Positive for hepatitis B virus antigen 9) Pregnancy 10) Others who are inadequate to entry this study |
|||
| Target sample size | 90 | |||
| Research contact person | |
| Name of lead principal investigator | Takashi Kamei |
| Organization | Tohoku University |
| Division name | Department of Surgery |
| Address | Seiryo-machi 1-1, Aobaku, Sendai,JAPAN |
| TEL | 022-717-7214 |
| tkamei@med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Takashi Kamei |
| Organization | Tohoku University |
| Division name | Department of Surgery |
| Address | Seiryo-machi 1-1, Aobaku, Sendai,JAPAN |
| TEL | 022-717-7214 |
| Homepage URL | |
| tkamei@med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Tohoku University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Grants-in-Aid for Scientific Research |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | No |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029405 |